Position in GERN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$19,806
-$3,250 QoQ
Shares Held
15,474
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#195
of 258 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Csenge Advisory Group holds $2,906,060 across 6 Biotechnology names. GERN ranks #6 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
5,037 | $1,213,765 | |
| 2 | ASND |
Ascendis Pharma A/S
|
2,171 | $579,049 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
2,067 | $505,939 | |
| 4 | RPRX |
Royalty Pharma plc
|
5,951 | $333,672 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
511 | $253,829 | |
| 6 | GERN |
Geron Corp
This page
|
15,474 | $19,806 |
All Filings in GERN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,806 | 15,474 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $23,056 | 15,474 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $20,425 | 15,474 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $21,199 | 15,474 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $21,818 | 15,474 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $25,109 | 15,792 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $54,777 | 15,474 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $70,251 | 15,474 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $65,609 | 15,474 | Shares | Sole | 2024-07-10 | |
| No filing history on record for this holder in this stock. | ||||||